
Jun Zhong MD Board Certified Psychiatrist (He/Him)
Addiction, Psychopharmacology, Integrative Psychiatry
ABPN Board Certified Psychiatrist,Medical Director
Join to View Full Profile
10752 N 89th PlaceSte C-230Scottsdale, AZ 85260
Phone+1 480-256-1680
Fax+1 888-609-4966
Dr. Zhong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jun Zhong is a psychiatrist in AZ. He received his medical degree from Southeast University Medical College and has been in practice 20 years. He specializes in addiction, psychopharmacology, and integrative psychiatry and is experienced in attention-deficit/hyperactivity disorder, substance-related and addictive disorders, mood disorders, anxiety disorders, and obsessive-compulsive and related disorders.
Clinical Expertise
- Attention-deficit/hyperactivity disorder, Substance-related and addictive disorders, Mood disorders, Anxiety disorders, Obsessive-compulsive and related disorders, Psychopharmacology
Education & Training
- Saint Elizabeths Hospital-DC Department of Behavioral HealthResidency, Psychiatry, 2014 - 2018
- Southeast University Medical CollegeClass of 1998, M.D.
Certifications & Licensure
- AZ State Medical License 2018 - 2026
- NV State Medical License 2020 - 2025
- WA State Medical License 2020 - 2024
- DC State Medical License 2014 - 2019
- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 4 citationsAbnormal fractional Amplitude of Low-Frequency Fluctuation in chronic ketamine users.Jun Zhong, Huawang Wu, Fengchun Wu, Hongbo He, Zhaohua Zhang
Psychiatry Research. Neuroimaging. 2022-10-01 - 8 citationsCortical Thickness Changes in Chronic Ketamine UsersJun Zhong, Huawang Wu, Fengchun Wu, Hongbo He, Zhaohua Zhang
Frontiers in Psychiatry. 2021-03-25 - 54 citationsClinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy.Jonathan Oliva, Scott Galasinski, Amelia Richey, Amy E. Campbell, Marvin J. Meyers
The Journal of Pharmacology and Experimental Therapeutics. 2019-08-01
Press Mentions
- Tracing Solute Sources and Carbon Dynamics Under Various Hydrological Conditions in a Karst River in Southwestern ChinaJanuary 21st, 2020
Professional Memberships
- Member
Other Languages
- Chinese (Mandarin)
External Links
- Home Pagehttp://www.sanctuarytreatmentcenter.net/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: